1162735712
- Increased Frequency of Peripheral B and T Cells Expressing Granulocyte Monocyte Colony-Stimulating Factor in Rheumatoid Arthritis Patients. Makris A, Adamidi S, Koutsianas C, Tsalapaki C, Hadziyannis E, Vassilopoulos D. Front Immunol. 2018 Jan 10;8:1967. doi: 10.3389/fimmu.2017.01967. eCollection 2017
- Impaired Antiatherogenic Functions of High-density Lipoprotein in Patients with Ankylosing Spondylitis. Christina Gkolfinopoulou, Efstratios Stratikos, Dimitris Theofilatos, Dimitris Kardassis, Paraskevi V. Voulgari, Alexandros A. Drosos and Angeliki Chroni. The Journal of Rheumatology August 2015, jrheum.141532; DOI: https://doi.org/10.3899/jrheum.141532
- Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations. Fotini Gravani1,2, Ioanna Papadaki1, Eleni Antypa3, Andrianos Nezos4, Kyriaki Masselou5, Dimitrios Ioakeimidis1, Michael Koutsilieris4, Haralampos M Moutsopoulos2 and Clio P Mavragani2,4*. Gravani et al. Arthritis Research & Therapy (2015) 17:99. DOI 10.1186/s13075-015-0613-6
- Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis. Adrianos Nezos a, Fotini Gravani b, Anna Tassidou c, Efstathia K. Kapsogeorgou d, Michael Voulgarelis d, Michael Koutsilieris a, Mary K. Crow e, 1, Clio P. Mavragani a, d, 1, *. https://doi.org/10.1016/j.jaut.2015.07.002
- Fatigue in Primary Sj€ogren’s Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations. THEOFANIS KARAGEORGAS, SOFIA FRAGIOUDAKI, ADRIANOS NEZOS, DIMITRIOS KARAISKOS, HARALAMPOS M. MOUTSOPOULOS, AND CLIO P. MAVRAGANI. Arthritis Care & Research. Vol. 68, No. 1, January 2016, pp 123–131. DOI 10.1002/acr.22720
- Adrenal Autoimmunity in Primary Sjogren’s Syndrome. Clio P. Mavragani,1 Marian Schini,1 Fotini Gravani,2 Gregorios Kaltsas,1 and Haralampos M. Moutsopoulos1. ARTHRITIS & RHEUMATISM. Vol. 64, No. 12, December 2012, pp 4066–4071. DOI 10.1002/art.34679
- Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance. Ilias Stagakis1,2†, George Bertsias1,2†, Stylianos Karvounaris1, Melina Kavousanaki1, Dimitra Virla3, Amalia Raptopoulou1, Dimitrios Kardassis3,4, Dimitrios T Boumpas1,2,4 and Prodromos I Sidiropoulos1*. https://doi.org/10.1186/ar3874
- Anti-TNFα treatment decreases the previously increased serum Indian Hedgehog levels in patients with ankylosing spondylitis and affects the expression of functional Hedgehog pathway target genes. Daoussis D, Filippopoulou A, Liossis SN, Sirinian C, Klavdianou K, Bouris P, Karamanos NK, Andonopoulos AP. Semin Arthritis Rheum. 2015 Jun;44(6):646-51. doi: 10.1016/j.semarthrit.2015.01.004. Epub 2015 Jan 2
